BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Soneji S, Yang J. New analysis reexamines the value of cancer care in the United States compared to Western Europe. Health Aff (Millwood) 2015;34:390-7. [PMID: 25732488 DOI: 10.1377/hlthaff.2014.0174] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Orangio GR. The Economics of Colon Cancer. Surg Oncol Clin N Am 2018;27:327-47. [PMID: 29496093 DOI: 10.1016/j.soc.2017.11.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
2 Jani C, Marshall DC, Singh H, Goodall R, Shalhoub J, Al Omari O, Salciccioli JD, Thomson CC. Lung cancer mortality in Europe and the USA between 2000 and 2017: an observational analysis. ERJ Open Res 2021;7:00311-2021. [PMID: 34988220 DOI: 10.1183/23120541.00311-2021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Howard DH, Chernew ME, Abdelgawad T, Smith GL, Sollano J, Grabowski DC. New Anticancer Drugs Associated With Large Increases In Costs And Life Expectancy. Health Aff (Millwood) 2016;35:1581-7. [PMID: 27605636 DOI: 10.1377/hlthaff.2016.0286] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 7.5] [Reference Citation Analysis]
4 Seabury SA, Goldman DP, Gupta CN, Khan ZM, Chandra A, Philipson TJ, Lakdawalla DN. Quantifying Gains in the War on Cancer Due to Improved Treatment and Earlier Detection. Forum Health Econ Policy 2016;19:141-56. [PMID: 31419891 DOI: 10.1515/fhep-2015-0028] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
5 Callahan R, Darzi A. Five Policy Levers To Meet The Value Challenge In Cancer Care. Health Affairs 2015;34:1563-8. [DOI: 10.1377/hlthaff.2015.0308] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
6 Carrera PM, Ormond M. Current practice in and considerations for personalized medicine in lung cancer: From the patient's molecular biology to patient values and preferences. Maturitas 2015;82:94-9. [DOI: 10.1016/j.maturitas.2015.04.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
7 Svynarenko R, Zhang Q, Kim H. The Financial Burden of Cancer: Financial Ratio Analysis. J Fam Econ Iss 2019;40:165-79. [DOI: 10.1007/s10834-018-9587-2] [Cited by in Crossref: 7] [Article Influence: 1.8] [Reference Citation Analysis]
8 Tom MC, Ross RB, Koyfman SA, Adelstein DJ, Lorenz RR, Burkey BB, Shah C, Suh JH, Bolwell BJ, Savage C, Platz S, Ward MC. Clinical Factors Associated With Cost in Head and Neck Cancer: Implications for a Bundled Payment Model. JOP 2019;15:e560-7. [DOI: 10.1200/jop.18.00665] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
9 Salas-Vega S, Mossialos E. Cancer Drugs Provide Positive Value In Nine Countries, But The United States Lags In Health Gains Per Dollar Spent. Health Aff (Millwood) 2016;35:813-23. [PMID: 27140987 DOI: 10.1377/hlthaff.2015.1453] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
10 Baumgardner JR, Brauer MS, Zhang J, Hao Y, Liu Z, Lakdawalla DN. CAR-T therapy and historical trends in effectiveness and cost–effectiveness of oncology treatments. Journal of Comparative Effectiveness Research 2020;9:327-40. [DOI: 10.2217/cer-2019-0065] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
11 Trooboff SW, Kang R, Margenthaler J, Wong SL. Choosing Wisely: Optimizing Routine Workup for the Newly Diagnosed Breast Cancer Patient. Curr Breast Cancer Rep 2018;10:62-73. [DOI: 10.1007/s12609-018-0268-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Leal J, Luengo-Fernandez R, Sullivan R, Witjes JA. Economic Burden of Bladder Cancer Across the European Union. Eur Urol 2016;69:438-47. [PMID: 26508308 DOI: 10.1016/j.eururo.2015.10.024] [Cited by in Crossref: 128] [Cited by in F6Publishing: 115] [Article Influence: 18.3] [Reference Citation Analysis]
13 Bateni SB, Gingrich AA, Hoch JS, Canter RJ, Bold RJ. Defining Value for Pancreatic Surgery in Early-Stage Pancreatic Cancer. JAMA Surg 2019;154:e193019. [PMID: 31433465 DOI: 10.1001/jamasurg.2019.3019] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
14 Syse A, Soneji SS, Andrew AS, Tretli S, Baili P, Bynum JPW. Short-term survival after colorectal cancer in a screened versus unscreened population. Scand J Public Health 2019;47:528-37. [PMID: 29360010 DOI: 10.1177/1403494817744394] [Reference Citation Analysis]
15 Chow RD, Bradley EH, Gross CP. Comparison of Cancer-Related Spending and Mortality Rates in the US vs 21 High-Income Countries. JAMA Health Forum 2022;3:e221229. [DOI: 10.1001/jamahealthforum.2022.1229] [Reference Citation Analysis]
16 Banks I, Weller D, Ungan M, Selby P, Aapro M, Beishon M, Bolt M, Bonanno F, Champeix C, Dégi C, Eneqvist LJ, Kazmierska J, Kolacinska A, Malas S, Moine S, Pavlic DR, Price R, Walter F, Wyld L. ECCO Essential Requirements for Quality Cancer Care: Primary care. Crit Rev Oncol Hematol 2019;142:187-99. [PMID: 31445441 DOI: 10.1016/j.critrevonc.2019.07.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]